Cell Biotech Co., Ltd. (KOSDAQ:049960)
13,800
+600 (4.55%)
At close: Jan 30, 2026
-4.17% (1Y)
| Market Cap | 90.34B |
| Revenue (ttm) | 50.65B -3.7% |
| Net Income | 12.59B +14.7% |
| EPS | 1,839.56 +14.7% |
| Shares Out | 6.84M |
| PE Ratio | 7.18 |
| Forward PE | n/a |
| Dividend | 450.00 (3.40%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 56,741 |
| Average Volume | 19,220 |
| Open | 13,290 |
| Previous Close | 13,200 |
| Day's Range | 13,290 - 13,960 |
| 52-Week Range | 11,350 - 14,660 |
| Beta | 0.28 |
| RSI | 51.40 |
| Earnings Date | Feb 13, 2026 |